PRS5 Cost-Effectiveness of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD) in the Netherlands
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2020 |
Reihe/Periodikum: | Value in Health ; volume 23, page S716-S717 ; ISSN 1098-3015 |
Verlag/Hrsg.: |
Elsevier BV
|
Schlagwörter: | Public Health / Environmental and Occupational Health / Health Policy |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27191154 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1016/j.jval.2020.08.1885 |